MejÃa-Guzmán, J.E.; Belmont-Hernández, R.A.; Chávez-Tapia, N.C.; Uribe, M.; Nuño-Lámbarri, N.
Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies. Int. J. Mol. Sci. 2025, 26, 2959.
https://doi.org/10.3390/ijms26072959
AMA Style
MejÃa-Guzmán JE, Belmont-Hernández RA, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N.
Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies. International Journal of Molecular Sciences. 2025; 26(7):2959.
https://doi.org/10.3390/ijms26072959
Chicago/Turabian Style
MejÃa-Guzmán, Jeysson E., Ramón A. Belmont-Hernández, Norberto C. Chávez-Tapia, Misael Uribe, and Natalia Nuño-Lámbarri.
2025. "Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies" International Journal of Molecular Sciences 26, no. 7: 2959.
https://doi.org/10.3390/ijms26072959
APA Style
MejÃa-Guzmán, J. E., Belmont-Hernández, R. A., Chávez-Tapia, N. C., Uribe, M., & Nuño-Lámbarri, N.
(2025). Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies. International Journal of Molecular Sciences, 26(7), 2959.
https://doi.org/10.3390/ijms26072959
